Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data

PaperCitations, authors & open-access status

Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 47 citations, 2020 year and green oa status.

47
Citations
2020
Year
green
OA Status

Related on ScholarIQ

Vakaramoko Diaby
Author
Antiplatelet Therapy and Cardiovascular Diseases
Topic
Antiplatelet Therapy and Cardiovascular Diseases
Topic
Health Systems, Economic Evaluations, Quality of Life
Topic
Atrial Fibrillation Management and Outcomes
Topic
470M+ articles · free account